Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IGC Pharma, Inc. Director's Dealing 2018

Jan 12, 2018

34705_dirs_2018-01-12_479d83fe-9687-4514-97b9-79453bf60aea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2018-01-10

Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-10 Common stock S 7738 $1.11 Disposed 2384256 Direct
2018-01-10 Common stock S 1203 $1.08 Disposed 2383053 Direct
2018-01-10 Common stock S 3059 $1.07 Disposed 2379994 Direct
2018-01-11 Common stock S 8000 $1.12 Disposed 2371994 Direct
2018-01-11 Common stock S 4000 $1.11 Disposed 2367994 Direct
2018-01-12 Common stock S 12000 $1.05 Disposed 2355994 Direct